You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Small-molecule and peptide inhibitors of m6A regulators
- 2. Genetic characterization of Lynch syndrome germline variants in a LATAM cohort using a customized NGS gene panel
- 3. A case report of advanced small intestinal stromal tumor with KIT gene mutation and BRCA2 deletion after multi-line treatments
- 4. Arginine methylation regulates Ewing sarcoma cell viability in a EWSR1::FLI1 dependent manner and provides a therapeutic opportunity
- 5. Pandemic darlings Moderna, BioNTech are now on two different paths
- 6. Nuvectis Pharma Provides Final Clinical Data Update from the NXP800 Phase 1b Study in Ovarian Cancer and Reports Completion of the NXP900 Phase 1a Dose Escalation Study
- 7. Unveiling large multimodal models in pulmonary CT: A comparative assessment of generative AI performance in lung cancer diagnostics
- 8. Development and validation of a Comprehensive Hematological Scoring System for predicting overall survival in patients with soft tissue sarcomas: a comparison with NLR and PLR
- 9. Beliefs about causes of cancer among students around the world
- 10. Cancer complexity: why we need a novel cancer research strategy
Last updated at 20:02 GMT
Hot News Makers
Health/Pharma Companies
-
162544.17
-
32783.72
-
24785.72
-
24468.54
-
15892.36
-
15597.73
-
14883.10
-
13382.62
-
12181.30
-
10319.65
Drugs, Treatments, Trials
-
34325.54
-
24899.17
-
13371.17
-
8047.18
-
4999.82
-
3796.86
-
2069.70
-
1592.07
-
1374.97
-
1209.98
Last updated at 19:10 GMT
